Global Biobanking Market 2022-2028

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. According to latest analysis by Publisher, the global biobanking market is poised to grow by USD 18 billion during 2022-2028, progressing at a CAGR of 4.5% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biobanking market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biobanking industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the sample type, ownership, application, and region. The global market for biobanking can be segmented by sample type: biofluids, DNA/RNA, stem cells, tissues, others. The biofluids segment held the largest revenue share in 2021. Biobanking market is further segmented by ownership: national & regional agencies, universities, non-profit organization, private organization. Among these, the national & regional agencies segment was accounted for the highest revenue generator in 2021. Based on application, the biobanking market is segmented into: research, therapeutics. The research segment captured the largest share of the market in 2021. On the basis of region, the biobanking market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, North America had the largest share in the global biobanking market.

By sample type:
- biofluids
- DNA/RNA
- stem cells
- tissues
- others

By ownership:
- national & regional agencies
- universities
- non-profit organization
- private organization



By application:
- research
- therapeutics

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The report has also analysed the competitive landscape of the global biobanking market with some of the key players being All of Us, Biobank Graz, Biobank VAST, Danish National Biobank, Kaiser Permanente Research Bank, National Liver Disease Biobank, The Cancer Human Biobank (caHUB), UK Biobank Limited, Uppsala Biobank, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global biobanking market.
- To classify and forecast the global biobanking market based on sample type, ownership, application, region.
- To identify drivers and challenges for the global biobanking market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biobanking market.
- To identify and analyze the profile of leading players operating in the global biobanking market.

Why Choose This Report
- Gain a reliable outlook of the global biobanking market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.